EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 162 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $3,098 | +3.3% | 106 | 0.0% | 0.00% | – |
Q3 2022 | $3,000 | -40.0% | 106 | 0.0% | 0.00% | – |
Q2 2022 | $5,000 | +150.0% | 106 | +130.4% | 0.00% | – |
Q1 2022 | $2,000 | 0.0% | 46 | -6.1% | 0.00% | – |
Q4 2021 | $2,000 | -33.3% | 49 | +2.1% | 0.00% | – |
Q3 2021 | $3,000 | +50.0% | 48 | 0.0% | 0.00% | – |
Q2 2021 | $2,000 | +100.0% | 48 | +54.8% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 31 | +19.2% | 0.00% | – |
Q4 2020 | $1,000 | -50.0% | 26 | -43.5% | 0.00% | – |
Q3 2020 | $2,000 | -50.0% | 46 | -47.7% | 0.00% | – |
Q2 2020 | $4,000 | 0.0% | 88 | -2.2% | 0.00% | – |
Q1 2020 | $4,000 | -33.3% | 90 | -5.3% | 0.00% | – |
Q4 2019 | $6,000 | +20.0% | 95 | +5.6% | 0.00% | – |
Q3 2019 | $5,000 | – | 90 | +4400.0% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 2 | -96.3% | 0.00% | – |
Q3 2017 | $3,000 | +50.0% | 54 | +170.0% | 0.00% | – |
Q2 2017 | $2,000 | – | 20 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |